FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Journal of orthopaedic research : official publication of the Orthopaedic Research Society2009; 27(12); 1675-1680; doi: 10.1002/jor.20933

Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis.

Abstract: The purpose of this study was the assessment of clinical, biochemical, and histologic effects of intraarticular administered adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. Osteoarthritis was induced arthroscopically in the middle carpal joint of all horses, the contralateral joint being sham-operated. All horses received treatment on Day 14. Eight horses received placebo treatment and eight horses received adipose-derived stromal vascular fraction in their osteoarthritis-affected joint. The final eight horses were treated the in osteoarthritis-affected joint with bone marrow-derived mesenchymal stem cells. Evaluations included clinical, radiographic, synovial fluid analysis, gross, histologic, histochemical, and biochemical evaluations. No adverse treatment-related events were observed. The model induced a significant change in all but two parameters, no significant treatment effects were demonstrated, with the exception of improvement in synovial fluid effusion PGE2 levels with bone marrow-derived mesenchymal stem cells when compared to placebo. A greater improvement was seen with bone marrow-derived mesenchymal stem cells when compared to adipose-derived stromal vascular fraction and placebo treatment. Overall, the findings of this study were not significant enough to recommend the use of stem cells for the treatment of osteoarthritis represented in this model.
Get Full Text
Publication Date: 2009-06-23 PubMed ID: 19544397DOI: 10.1002/jor.20933Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigated the effectiveness of two types of stem cells, adipose-derived stromal vascular fraction and bone marrow-derived mesenchymal stem cells, in treating osteoarthritis. Despite observing some improvements, the results weren’t significant enough to advise their use in treating osteoarthritis.

Research Methodology

  • The aim of the study was to test the effects of injecting two types of stem cells – adipose-derived stromal vascular fraction (AD-SVF) and bone marrow-derived mesenchymal stem cells (BM-MSCs) – directly into the joints of horses suffering from osteoarthritis.
  • The researchers artificially induced osteoarthritis in the middle carpal joint of all horses involved in the study.
  • The contralateral joint, the joint on the opposite side, of each horse was sham-operated, meaning it was prepared and treated as if it was going to be operated on, but the actual surgical procedure was not carried out.
  • Treatment began two weeks into the study. The horses were divided into three groups – one group was given a placebo, one was treated with AD-SVF, and the last with BM-MSCs.

Research Findings

  • All treatment procedures were accomplished without causing any adverse reactions or side effects.
  • The induced osteoarthritis resulted in significant changes to nearly all measured parameters, suggesting the induction procedure was effective.
  • No significant treatment effects were observed overall, except for a decrease in the level of synovial fluid effusion PGE2 with the use of BM-MSCs, compared to the placebo treatment.
  • BM-MSCs were also seen to be more effective at reducing synovial fluid effusion PGE2 levels than AD-SVF.
  • However, the improvements recorded were not marked enough to conclusively suggest the use of stem cell therapy for osteoarthritis treatment.

Conclusions

  • While the study observed some minimal positive effects of BM-MSCs, particularly in comparison to both the placebo and AD-SVF treatments, the overall findings do not strongly advocate for the use of stem cells in treating osteoarthritis in this model.

Cite This Article

APA
Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM, McIlwraith CW. (2009). Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. J Orthop Res, 27(12), 1675-1680. https://doi.org/10.1002/jor.20933

Publication

Journal of orthopaedic research : official publication of the Orthopaedic Research Society
ISSN: 1554-527X
NlmUniqueID: 8404726
Country: United States
Language: English
Volume: 27
Issue: 12
Pages: 1675-1680

Researcher Affiliations

Frisbie, David D
  • Equine Orthopaedic Research Center, Department of Clinical Sciences, Colorado State University, 300 West Drake Road, Fort Collins, Colorado 80523, USA. dfrisbie@colostate.edu
Kisiday, John D
    Kawcak, Chris E
      Werpy, Natasha M
        McIlwraith, C Wayne

          MeSH Terms

          • Adipocytes / cytology
          • Animals
          • Arthritis, Experimental
          • Arthroscopy
          • Cells, Cultured
          • Hematopoietic Stem Cell Transplantation / methods
          • Horse Diseases / therapy
          • Horses
          • Mesenchymal Stem Cell Transplantation / methods
          • Mesenchymal Stem Cells / cytology
          • Osteoarthritis / diagnostic imaging
          • Osteoarthritis / pathology
          • Osteoarthritis / therapy
          • Physical Conditioning, Animal
          • Radiography
          • Stifle / pathology
          • Stifle / physiopathology
          • Stifle / surgery
          • Stromal Cells / cytology
          • Synovial Fluid / cytology
          • Synovial Fluid / metabolism
          • Synovial Fluid / physiology

          Citations

          This article has been cited 104 times.
          1. Luque RM, Henderson B, McCorkell TC, Alizadeh AH, Russell KA, Koch TG, Koenig J. Treatment outcomes for equine osteoarthritis with mesenchymal stromal cells and hyaluronic acid. Equine Vet J 2025 Sep;57(5):1245-1254.
            doi: 10.1111/evj.14531pubmed: 40364589google scholar: lookup
          2. Morawska-Kozłowska M, Pitas M, Zhalniarovich Y. Mesenchymal Stem Cells in Veterinary Medicine-Still Untapped Potential. Animals (Basel) 2025 Apr 19;15(8).
            doi: 10.3390/ani15081175pubmed: 40282009google scholar: lookup
          3. Esselman AM, Johnson SA, Hague BA, Frisbie DD. Severity, distribution and postoperative therapy are not predictors of return to work in western performance horses with stifle chondromalacia. Vet Surg 2025 Jul;54(5):831-839.
            doi: 10.1111/vsu.14196pubmed: 40059430google scholar: lookup
          4. Chow L, Kawahisa-Piquini G, Bass L, Hendrickson D, Patel A, Rockow M, Dow S, Pezzanite LM. Correlation of fecal microbiome dysregulation to synovial transcriptome in an equine model of obesity associated osteoarthritis. Ann Transl Med 2024 Dec 24;12(6):112.
            doi: 10.21037/atm-24-109pubmed: 39817240google scholar: lookup
          5. Wu KC, Chang YH, Ding DC, Lin SZ. Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review. Int J Mol Sci 2024 Nov 30;25(23).
            doi: 10.3390/ijms252312911pubmed: 39684619google scholar: lookup
          6. Noorwali A, Aljoud F, Alghamdi A, Sattami N, Bashah T, Noorwali A, Pushparaj PN, Gauthaman K. Evaluation of serum biomarkers after intra-articular injection of rat bone marrow-derived mesenchymal stem cells in a rat model of knee osteoarthritis. Heliyon 2024 Nov 15;10(21):e39940.
            doi: 10.1016/j.heliyon.2024.e39940pubmed: 39553645google scholar: lookup
          7. Khatibzadeh SM, Dahlgren LA, Caswell CC, Ducker WA, Werre SR, Bogers SH. Equine bone marrow-derived mesenchymal stromal cells reduce established S. aureus and E. coli biofilm matrix in vitro. PLoS One 2024;19(10):e0312917.
            doi: 10.1371/journal.pone.0312917pubmed: 39480794google scholar: lookup
          8. Heyman E, Devriendt B, De Vlieghere E, Goethals K, Van Poucke M, Peelman L, De Schauwer C. Evaluation of enzymatic protocols to optimize efficiency of bovine adipose tissue-derived mesenchymal stromal cell isolation. NPJ Sci Food 2024 Oct 1;8(1):70.
            doi: 10.1038/s41538-024-00313-7pubmed: 39353952google scholar: lookup
          9. Reynolds DE, Vallapureddy P, Morales RT, Oh D, Pan M, Chintapula U, Linardi RL, Gaesser AM, Ortved K, Ko J. Equine mesenchymal stem cell derived extracellular vesicle immunopathology biomarker discovery. J Extracell Biol 2023 Jun;2(6):e89.
            doi: 10.1002/jex2.89pubmed: 38938916google scholar: lookup
          10. Andersen C, Walters M, Bundgaard L, Berg LC, Vonk LA, Lundgren-Åkerlund E, Henriksen BL, Lindegaard C, Skovgaard K, Jacobsen S. Intraarticular treatment with integrin α10β1-selected mesenchymal stem cells affects microRNA expression in experimental post-traumatic osteoarthritis in horses. Front Vet Sci 2024;11:1374681.
            doi: 10.3389/fvets.2024.1374681pubmed: 38596460google scholar: lookup
          11. Andersen C, Jacobsen S, Uvebrant K, Griffin JF 4th, Vonk LA, Walters M, Berg LC, Lundgren-Åkerlund E, Lindegaard C. Integrin α10β1-Selected Mesenchymal Stem Cells Reduce Pain and Cartilage Degradation and Increase Immunomodulation in an Equine Osteoarthritis Model. Cartilage 2025 Jun;16(2):250-264.
            doi: 10.1177/19476035231209402pubmed: 37990503google scholar: lookup
          12. O'Brien TJ, Hollinshead F, Goodrich LR. Extracellular vesicles in the treatment and prevention of osteoarthritis: can horses help us translate this therapy to humans?. Extracell Vesicles Circ Nucl Acids 2023 Jun;4(2):151-169.
            doi: 10.20517/evcna.2023.11pubmed: 37829144google scholar: lookup
          13. Tamura N, Heidari N, Faragher RGA, Smith RKW, Dudhia J. Effects of resveratrol and its analogues on the cell cycle of equine mesenchymal stem/stromal cells. J Equine Sci 2023 Sep;34(3):67-72.
            doi: 10.1294/jes.34.67pubmed: 37781569google scholar: lookup
          14. Li H, Xiong S, Masieri FF, Monika S, Lethaus B, Savkovic V. Mesenchymal Stem Cells Isolated from Equine Hair Follicles Using a Method of Air-Liquid Interface. Stem Cell Rev Rep 2023 Nov;19(8):2943-2956.
            doi: 10.1007/s12015-023-10619-wpubmed: 37733199google scholar: lookup
          15. Mayet A, Zablotski Y, Roth SP, Brehm W, Troillet A. Systematic review and meta-analysis of positive long-term effects after intra-articular administration of orthobiologic therapeutics in horses with naturally occurring osteoarthritis. Front Vet Sci 2023;10:1125695.
            doi: 10.3389/fvets.2023.1125695pubmed: 36908512google scholar: lookup
          16. Pezzanite LM, Chow L, Griffenhagen GM, Bass L, Goodrich LR, Impastato R, Dow S. Distinct differences in immunological properties of equine orthobiologics revealed by functional and transcriptomic analysis using an activated macrophage readout system. Front Vet Sci 2023;10:1109473.
            doi: 10.3389/fvets.2023.1109473pubmed: 36876001google scholar: lookup
          17. Lv Z, Cai X, Bian Y, Wei Z, Zhu W, Zhao X, Weng X. Advances in Mesenchymal Stem Cell Therapy for Osteoarthritis: From Preclinical and Clinical Perspectives. Bioengineering (Basel) 2023 Feb 2;10(2).
            doi: 10.3390/bioengineering10020195pubmed: 36829689google scholar: lookup
          18. Boffa A, Perucca Orfei C, Sourugeon Y, Laver L, Magalon J, Sánchez M, Tischer T, de Girolamo L, Filardo G. Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic Initiative. Part 2: bone marrow-derived cell-based injectable therapies. Knee Surg Sports Traumatol Arthrosc 2023 Aug;31(8):3230-3242.
            doi: 10.1007/s00167-023-07320-3pubmed: 36823238google scholar: lookup
          19. Farid MF, Abouelela YS, Yasin NAE, Al-Mokaddem AK, Prince A, Ibrahim MA, Rizk H. Laser-activated autologous adipose tissue-derived stromal vascular fraction restores spinal cord architecture and function in multiple sclerosis cat model. Stem Cell Res Ther 2023 Jan 11;14(1):6.
            doi: 10.1186/s13287-022-03222-2pubmed: 36627662google scholar: lookup
          20. Clarke EJ, Johnson E, Caamaño Gutierrez E, Andersen C, Berg LC, Jenkins RE, Lindegaard C, Uvebrant K, Lundgren-Åkerlund E, Turlo A, James V, Jacobsen S, Peffers MJ. Temporal extracellular vesicle protein changes following intraarticular treatment with integrin α10β1-selected mesenchymal stem cells in equine osteoarthritis. Front Vet Sci 2022;9:1057667.
            doi: 10.3389/fvets.2022.1057667pubmed: 36504839google scholar: lookup
          21. Perucca Orfei C, Boffa A, Sourugeon Y, Laver L, Magalon J, Sánchez M, Tischer T, Filardo G, de Girolamo L. Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic Initiative. Part 1: adipose tissue-derived cell-based injectable therapies. Knee Surg Sports Traumatol Arthrosc 2023 Feb;31(2):641-655.
            doi: 10.1007/s00167-022-07063-7pubmed: 36104484google scholar: lookup
          22. Zhu Y, Fu W. Peripheral Blood-Derived Stem Cells for the Treatment of Cartilage Injuries: A Systematic Review. Front Bioeng Biotechnol 2022;10:956614.
            doi: 10.3389/fbioe.2022.956614pubmed: 35935493google scholar: lookup
          23. Sharun K, Jambagi K, Kumar R, Gugjoo MB, Pawde AM, Tuli HS, Dhama K, Amarpal. Clinical applications of adipose-derived stromal vascular fraction in veterinary practice. Vet Q 2022 Dec;42(1):151-166.
            doi: 10.1080/01652176.2022.2102688pubmed: 35841195google scholar: lookup
          24. Kearney CM, Khatab S, van Buul GM, Plomp SGM, Korthagen NM, Labberté MC, Goodrich LR, Kisiday JD, Van Weeren PR, van Osch GJVM, Brama PAJ. Treatment Effects of Intra-Articular Allogenic Mesenchymal Stem Cell Secretome in an Equine Model of Joint Inflammation. Front Vet Sci 2022;9:907616.
            doi: 10.3389/fvets.2022.907616pubmed: 35812845google scholar: lookup
          25. Andersen C, Jacobsen S, Walters M, Lindegaard C. A detailed macroscopic scoring system for experimental post-traumatic Osteoarthritis in the equine middle carpal joint. BMC Res Notes 2022 Jun 27;15(1):226.
            doi: 10.1186/s13104-022-06116-xpubmed: 35761416google scholar: lookup
          26. Yamada ALM, do Prado Vendruscolo C, Marsiglia MF, Sotelo EDP, Agreste FR, Seidel SRT, Fülber J, Baccarin RYA, da Silva LCLC. Effects of oral treatment with chondroitin sulfate and glucosamine in an experimental model of metacarpophalangeal osteoarthritis in horses. BMC Vet Res 2022 Jun 9;18(1):215.
            doi: 10.1186/s12917-022-03323-3pubmed: 35681208google scholar: lookup
          27. Kamada K, Matsushita T, Yamashita T, Matsumoto T, Iwaguro H, Sobajima S, Kuroda R. Attenuation of Knee Osteoarthritis Progression in Mice through Polarization of M2 Macrophages by Intra-Articular Transplantation of Non-Cultured Human Adipose-Derived Regenerative Cells. J Clin Med 2021 Sep 22;10(19).
            doi: 10.3390/jcm10194309pubmed: 34640324google scholar: lookup
          28. Lee S, Chae DS, Song BW, Lim S, Kim SW, Kim IK, Hwang KC. ADSC-Based Cell Therapies for Musculoskeletal Disorders: A Review of Recent Clinical Trials. Int J Mol Sci 2021 Sep 30;22(19).
            doi: 10.3390/ijms221910586pubmed: 34638927google scholar: lookup
          29. Ganiev I, Alexandrova N, Aimaletdinov A, Rutland C, Malanyeva A, Rizvanov A, Zakirova E. The treatment of articular cartilage injuries with mesenchymal stem cells in different animal species. Open Vet J 2021 Jan-Mar;11(1):128-134.
            doi: 10.4314/ovj.v11i1.19pubmed: 33898294google scholar: lookup
          30. Bertoni L, Jacquet-Guibon S, Branly T, Desancé M, Legendre F, Melin M, Rivory P, Hartmann DJ, Schmutz A, Denoix JM, Demoor M, Audigié F, Galéra P. Evaluation of Allogeneic Bone-Marrow-Derived and Umbilical Cord Blood-Derived Mesenchymal Stem Cells to Prevent the Development of Osteoarthritis in An Equine Model. Int J Mol Sci 2021 Mar 2;22(5).
            doi: 10.3390/ijms22052499pubmed: 33801461google scholar: lookup
          31. Markov A, Thangavelu L, Aravindhan S, Zekiy AO, Jarahian M, Chartrand MS, Pathak Y, Marofi F, Shamlou S, Hassanzadeh A. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther 2021 Mar 18;12(1):192.
            doi: 10.1186/s13287-021-02265-1pubmed: 33736695google scholar: lookup
          32. Veronesi F, Maglio M, Contartese D, Martini L, Muttini A, Fini M. Stromal Vascular Fraction and Amniotic Epithelial Cells: Preclinical and Clinical Relevance in Musculoskeletal Regenerative Medicine. Stem Cells Int 2021;2021:6632052.
            doi: 10.1155/2021/6632052pubmed: 33688354google scholar: lookup
          33. Ribitsch I, Oreff GL, Jenner F. Regenerative Medicine for Equine Musculoskeletal Diseases. Animals (Basel) 2021 Jan 19;11(1).
            doi: 10.3390/ani11010234pubmed: 33477808google scholar: lookup
          34. Qu H, Sun S. Efficacy of mesenchymal stromal cells for the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. J Orthop Surg Res 2021 Jan 6;16(1):11.
            doi: 10.1186/s13018-020-02128-0pubmed: 33407686google scholar: lookup
          35. Zhou X, Liang H, Hu X, An J, Ding S, Yu S, Liu C, Li F, Xu Y. BMSC-derived exosomes from congenital polydactyly tissue alleviate osteoarthritis by promoting chondrocyte proliferation. Cell Death Discov 2020 Dec 10;6(1):142.
            doi: 10.1038/s41420-020-00374-zpubmed: 33303743google scholar: lookup
          36. Velloso Alvarez A, Boone LH, Braim AP, Taintor JS, Caldwell F, Wright JC, Wooldridge AA. A Survey of Clinical Usage of Non-steroidal Intra-Articular Therapeutics by Equine Practitioners. Front Vet Sci 2020;7:579967.
            doi: 10.3389/fvets.2020.579967pubmed: 33195592google scholar: lookup
          37. Kusuma HSW, Widowati W, Gunanegara RF, Juliandi B, Lister NE, Arumwardana S, Yusepany DT, Artie DS, Nataya ED, Gunawan KY, Sholihah IA, Girsang E, Ginting CN, Bachtiar I, Murti H. Effect of Conditioned Medium from IGF1-Induced Human Wharton's Jelly Mesenchymal Stem Cells (IGF1-hWJMSCs-CM) on Osteoarthritis. Avicenna J Med Biotechnol 2020 Jul-Sep;12(3):172-178.
            pubmed: 32695280
          38. Hotham WE, Henson FMD. The use of large animals to facilitate the process of MSC going from laboratory to patient-'bench to bedside'. Cell Biol Toxicol 2020 Apr;36(2):103-114.
            doi: 10.1007/s10565-020-09521-9pubmed: 32206986google scholar: lookup
          39. Gugjoo MB, Hussain S, Amarpal, Shah RA, Dhama K. Mesenchymal Stem Cell-Mediated Immuno-Modulatory and Anti- Inflammatory Mechanisms in Immune and Allergic Disorders. Recent Pat Inflamm Allergy Drug Discov 2020;14(1):3-14.
            doi: 10.2174/1872213X14666200130100236pubmed: 32000656google scholar: lookup
          40. Colbath AC, Dow SW, Hopkins LS, Phillips JN, McIlwraith CW, Goodrich LR. Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis. Equine Vet J 2020 Jul;52(4):601-612.
            doi: 10.1111/evj.13222pubmed: 31821594google scholar: lookup
          41. Born S, Dörfel MJ, Hartjen P, Haschemi Yekani SA, Luecke J, Meutsch JK, Westphal JK, Birkelbach M, Köhnke R, Smeets R, Krueger M. A short-term plastic adherence incubation of the stromal vascular fraction leads to a predictable GMP-compliant cell-product. Bioimpacts 2019;9(3):161-172.
            doi: 10.15171/bi.2019.20pubmed: 31508331google scholar: lookup
          42. Magri C, Schramme M, Febre M, Cauvin E, Labadie F, Saulnier N, François I, Lechartier A, Aebischer D, Moncelet AS, Maddens S. Comparison of efficacy and safety of single versus repeated intra-articular injection of allogeneic neonatal mesenchymal stem cells for treatment of osteoarthritis of the metacarpophalangeal/metatarsophalangeal joint in horses: A clinical pilot study. PLoS One 2019;14(8):e0221317.
            doi: 10.1371/journal.pone.0221317pubmed: 31465445google scholar: lookup
          43. Sakamoto T, Miyazaki T, Watanabe S, Takahashi A, Honjoh K, Nakajima H, Oki H, Kokubo Y, Matsumine A. Intraarticular injection of processed lipoaspirate cells has anti-inflammatory and analgesic effects but does not improve degenerative changes in murine monoiodoacetate-induced osteoarthritis. BMC Musculoskelet Disord 2019 Jul 19;20(1):335.
            doi: 10.1186/s12891-019-2710-1pubmed: 31324245google scholar: lookup
          44. Hashimoto Y, Nishida Y, Takahashi S, Nakamura H, Mera H, Kashiwa K, Yoshiya S, Inagaki Y, Uematsu K, Tanaka Y, Asada S, Akagi M, Fukuda K, Hosokawa Y, Myoui A, Kamei N, Ishikawa M, Adachi N, Ochi M, Wakitani S. Transplantation of autologous bone marrow-derived mesenchymal stem cells under arthroscopic surgery with microfracture versus microfracture alone for articular cartilage lesions in the knee: A multicenter prospective randomized control clinical trial. Regen Ther 2019 Dec;11:106-113.
            doi: 10.1016/j.reth.2019.06.002pubmed: 31312692google scholar: lookup
          45. Gugjoo MB, Fazili MR, Gayas MA, Ahmad RA, Dhama K. Animal mesenchymal stem cell research in cartilage regenerative medicine - a review. Vet Q 2019 Dec;39(1):95-120.
            doi: 10.1080/01652176.2019.1643051pubmed: 31291836google scholar: lookup
          46. Broeckx SY, Martens AM, Bertone AL, Van Brantegem L, Duchateau L, Van Hecke L, Dumoulin M, Oosterlinck M, Chiers K, Hussein H, Pille F, Spaas JH. The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study. Equine Vet J 2019 Nov;51(6):787-794.
            doi: 10.1111/evj.13089pubmed: 30815897google scholar: lookup
          47. Harrison-Brown M, Scholes C, Hafsi K, Marenah M, Li J, Hassan F, Maffulli N, Murrell WD. Efficacy and safety of culture-expanded, mesenchymal stem/stromal cells for the treatment of knee osteoarthritis: a systematic review protocol. J Orthop Surg Res 2019 Jan 25;14(1):34.
            doi: 10.1186/s13018-019-1070-8pubmed: 30683159google scholar: lookup
          48. Broeckx SY, Seys B, Suls M, Vandenberghe A, Mariën T, Adriaensen E, Declercq J, Van Hecke L, Braun G, Hellmann K, Spaas JH. Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses. Stem Cells Dev 2019 Mar 15;28(6):410-422.
            doi: 10.1089/scd.2018.0061pubmed: 30623737google scholar: lookup
          49. Barrachina L, Remacha AR, Romero A, Vitoria A, Albareda J, Prades M, Roca M, Zaragoza P, Vázquez FJ, Rodellar C. Assessment of effectiveness and safety of repeat administration of proinflammatory primed allogeneic mesenchymal stem cells in an equine model of chemically induced osteoarthritis. BMC Vet Res 2018 Aug 17;14(1):241.
            doi: 10.1186/s12917-018-1556-3pubmed: 30119668google scholar: lookup
          50. Shah K, Drury T, Roic I, Hansen P, Malin M, Boyd R, Sumer H, Ferguson R. Outcome of Allogeneic Adult Stem Cell Therapy in Dogs Suffering from Osteoarthritis and Other Joint Defects. Stem Cells Int 2018;2018:7309201.
            doi: 10.1155/2018/7309201pubmed: 30050578google scholar: lookup
          51. Shin YS, Yoon JR, Kim HS, Lee SH. Intra-Articular Injection of Bone Marrow-Derived Mesenchymal Stem Cells Leading to Better Clinical Outcomes without Difference in MRI Outcomes from Baseline in Patients with Knee Osteoarthritis. Knee Surg Relat Res 2018 Sep 1;30(3):206-214.
            doi: 10.5792/ksrr.17.201pubmed: 29983008google scholar: lookup
          52. Shaw B, Darrow M, Derian A. Short-Term Outcomes in Treatment of Knee Osteoarthritis With 4 Bone Marrow Concentrate Injections. Clin Med Insights Arthritis Musculoskelet Disord 2018;11:1179544118781080.
            doi: 10.1177/1179544118781080pubmed: 29977117google scholar: lookup
          53. Bogers SH. Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know. Front Vet Sci 2018;5:70.
            doi: 10.3389/fvets.2018.00070pubmed: 29713634google scholar: lookup
          54. Kong L, Zheng LZ, Qin L, Ho KKW. Role of mesenchymal stem cells in osteoarthritis treatment. J Orthop Translat 2017 Apr;9:89-103.
            doi: 10.1016/j.jot.2017.03.006pubmed: 29662803google scholar: lookup
          55. Barboni B, Russo V, Berardinelli P, Mauro A, Valbonetti L, Sanyal H, Canciello A, Greco L, Muttini A, Gatta V, Stuppia L, Mattioli M. Placental Stem Cells from Domestic Animals: Translational Potential and Clinical Relevance. Cell Transplant 2018 Jan;27(1):93-116.
            doi: 10.1177/0963689717724797pubmed: 29562773google scholar: lookup
          56. Stancker TG, Vieira SS, Serra AJ, do Nascimento Lima R, Dos Santos Feliciano R, Silva JA Jr, Dos Santos SA, Dos Santos Vieira MA, Simões MCB, Leal-Junior EC, de Tarso Camillo de Carvalho P. Can photobiomodulation associated with implantation of mesenchymal adipose-derived stem cells attenuate the expression of MMPs and decrease degradation of type II collagen in an experimental model of osteoarthritis?. Lasers Med Sci 2018 Jul;33(5):1073-1084.
            doi: 10.1007/s10103-018-2466-0pubmed: 29520686google scholar: lookup
          57. Schröck C, Eydt C, Geburek F, Kaiser L, Päbst F, Burk J, Pfarrer C, Staszyk C. Bone marrow-derived multipotent mesenchymal stromal cells from horses after euthanasia. Vet Med Sci 2017 Nov;3(4):239-251.
            doi: 10.1002/vms3.74pubmed: 29152317google scholar: lookup
          58. Berebichez-Fridman R, Gómez-García R, Granados-Montiel J, Berebichez-Fastlicht E, Olivos-Meza A, Granados J, Velasquillo C, Ibarra C. The Holy Grail of Orthopedic Surgery: Mesenchymal Stem Cells-Their Current Uses and Potential Applications. Stem Cells Int 2017;2017:2638305.
            doi: 10.1155/2017/2638305pubmed: 28698718google scholar: lookup
          59. Bertone AL, Reisbig NA, Kilborne AH, Kaido M, Salmanzadeh N, Lovasz R, Sizemore JL, Scheuermann L, Kopp RJ, Zekas LJ, Brokken MT. Equine Dental Pulp Connective Tissue Particles Reduced Lameness in Horses in a Controlled Clinical Trial. Front Vet Sci 2017;4:31.
            doi: 10.3389/fvets.2017.00031pubmed: 28344975google scholar: lookup
          60. Lang HM, Schnabel LV, Cassano JM, Fortier LA. Effect of needle diameter on the viability of equine bone marrow derived mesenchymal stem cells. Vet Surg 2017 Jul;46(5):731-737.
            doi: 10.1111/vsu.12639pubmed: 28328147google scholar: lookup
          61. Nguyen PD, Tran TD, Nguyen HT, Vu HT, Le PT, Phan NL, Vu NB, Phan NK, Van Pham P. Comparative Clinical Observation of Arthroscopic Microfracture in the Presence and Absence of a Stromal Vascular Fraction Injection for Osteoarthritis. Stem Cells Transl Med 2017 Jan;6(1):187-195.
            doi: 10.5966/sctm.2016-0023pubmed: 28170179google scholar: lookup
          62. Shipp SL, Cline MA, Gilbert ER. Recent advances in the understanding of how neuropeptide Y and α-melanocyte stimulating hormone function in adipose physiology. Adipocyte 2016 Oct-Dec;5(4):333-350.
            doi: 10.1080/21623945.2016.1208867pubmed: 27994947google scholar: lookup
          63. Gupta PK, Chullikana A, Rengasamy M, Shetty N, Pandey V, Agarwal V, Wagh SY, Vellotare PK, Damodaran D, Viswanathan P, Thej C, Balasubramanian S, Majumdar AS. Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Res Ther 2016 Dec 20;18(1):301.
            doi: 10.1186/s13075-016-1195-7pubmed: 27993154google scholar: lookup
          64. Bembo F, Eraud J, Philandrianos C, Bertrand B, Silvestre A, Veran J, Sabatier F, Magalon G, Magalon J. Combined use of platelet rich plasma & micro-fat in sport and race horses with degenerative joint disease: preliminary clinical study in eight horses. Muscles Ligaments Tendons J 2016 Apr-Jun;6(2):198-204.
            doi: 10.11138/mltj/2016.6.2.198pubmed: 27900293google scholar: lookup
          65. Maumus M, Roussignol G, Toupet K, Penarier G, Bentz I, Teixeira S, Oustric D, Jung M, Lepage O, Steinberg R, Jorgensen C, Noel D. Utility of a Mouse Model of Osteoarthritis to Demonstrate Cartilage Protection by IFNγ-Primed Equine Mesenchymal Stem Cells. Front Immunol 2016;7:392.
            doi: 10.3389/fimmu.2016.00392pubmed: 27729913google scholar: lookup
          66. Tyrnenopoulou P, Karayannopoulou M, Angelopoulou S, Pyrros A, Mparous E, Koliakos G, Diakakis N. Successful management of an equine carpal chip fracture by intra-articularly injected adipose-derived stromal vascular fraction after arthroscopic removal. Iran J Vet Res 2016 Winter;17(1):59-61.
            pubmed: 27656232
          67. Van Pham P, Hong-Thien Bui K, Quoc Ngo D, Tan Khuat L, Kim Phan N. Transplantation of Nonexpanded Adipose Stromal Vascular Fraction and Platelet-Rich Plasma for Articular Cartilage Injury Treatment in Mice Model. J Med Eng 2013;2013:832396.
            doi: 10.1155/2013/832396pubmed: 27006923google scholar: lookup
          68. Richards MM, Maxwell JS, Weng L, Angelos MG, Golzarian J. Intra-articular treatment of knee osteoarthritis: from anti-inflammatories to products of regenerative medicine. Phys Sportsmed 2016;44(2):101-8.
            doi: 10.1080/00913847.2016.1168272pubmed: 26985986google scholar: lookup
          69. Pak J, Lee JH, Kartolo WA, Lee SH. Cartilage Regeneration in Human with Adipose Tissue-Derived Stem Cells: Current Status in Clinical Implications. Biomed Res Int 2016;2016:4702674.
            doi: 10.1155/2016/4702674pubmed: 26881220google scholar: lookup
          70. Lombana KG, Goodrich LR, Phillips JN, Kisiday JD, Ruple-Czerniak A, McIlwraith CW. An Investigation of Equine Mesenchymal Stem Cell Characteristics from Different Harvest Sites: More Similar Than Not. Front Vet Sci 2015;2:67.
            doi: 10.3389/fvets.2015.00067pubmed: 26664993google scholar: lookup
          71. Wyles CC, Houdek MT, Behfar A, Sierra RJ. Mesenchymal stem cell therapy for osteoarthritis: current perspectives. Stem Cells Cloning 2015;8:117-24.
            doi: 10.2147/SCCAA.S68073pubmed: 26357483google scholar: lookup
          72. Kuroda K, Kabata T, Hayashi K, Maeda T, Kajino Y, Iwai S, Fujita K, Hasegawa K, Inoue D, Sugimoto N, Tsuchiya H. The paracrine effect of adipose-derived stem cells inhibits osteoarthritis progression. BMC Musculoskelet Disord 2015 Sep 3;16:236.
            doi: 10.1186/s12891-015-0701-4pubmed: 26336958google scholar: lookup
          73. Perdisa F, Gostyńska N, Roffi A, Filardo G, Marcacci M, Kon E. Adipose-Derived Mesenchymal Stem Cells for the Treatment of Articular Cartilage: A Systematic Review on Preclinical and Clinical Evidence. Stem Cells Int 2015;2015:597652.
            doi: 10.1155/2015/597652pubmed: 26240572google scholar: lookup
          74. Tessier L, Bienzle D, Williams LB, Koch TG. Phenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells. PLoS One 2015;10(4):e0122954.
            doi: 10.1371/journal.pone.0122954pubmed: 25902064google scholar: lookup
          75. Wolfstadt JI, Cole BJ, Ogilvie-Harris DJ, Viswanathan S, Chahal J. Current concepts: the role of mesenchymal stem cells in the management of knee osteoarthritis. Sports Health 2015 Jan;7(1):38-44.
            doi: 10.1177/1941738114529727pubmed: 25553211google scholar: lookup
          76. Counsel PD, Bates D, Boyd R, Connell DA. Cell therapy in joint disorders. Sports Health 2015 Jan;7(1):27-37.
            doi: 10.1177/1941738114523387pubmed: 25553210google scholar: lookup
          77. Lai JH, Rogan H, Kajiyama G, Goodman SB, Smith RL, Maloney W, Yang F. Interaction between osteoarthritic chondrocytes and adipose-derived stem cells is dependent on cell distribution in three-dimension and transforming growth factor-β3 induction. Tissue Eng Part A 2015 Mar;21(5-6):992-1002.
            doi: 10.1089/ten.TEA.2014.0244pubmed: 25315023google scholar: lookup
          78. Garvican ER, Cree S, Bull L, Smith RK, Dudhia J. Viability of equine mesenchymal stem cells during transport and implantation. Stem Cell Res Ther 2014 Aug 8;5(4):94.
            doi: 10.1186/scrt483pubmed: 25107289google scholar: lookup
          79. Paterson YZ, Rash N, Garvican ER, Paillot R, Guest DJ. Equine mesenchymal stromal cells and embryo-derived stem cells are immune privileged in vitro. Stem Cell Res Ther 2014 Jul 30;5(4):90.
            doi: 10.1186/scrt479pubmed: 25080326google scholar: lookup
          80. Zhang N, Dietrich MA, Lopez MJ. Therapeutic doses of multipotent stromal cells from minimal adipose tissue. Stem Cell Rev Rep 2014 Aug;10(4):600-11.
            doi: 10.1007/s12015-014-9508-1pubmed: 24850472google scholar: lookup
          81. Song F, Tang J, Geng R, Hu H, Zhu C, Cui W, Fan W. Comparison of the efficacy of bone marrow mononuclear cells and bone mesenchymal stem cells in the treatment of osteoarthritis in a sheep model. Int J Clin Exp Pathol 2014;7(4):1415-26.
            pubmed: 24817937
          82. Broeckx S, Zimmerman M, Crocetti S, Suls M, Mariën T, Ferguson SJ, Chiers K, Duchateau L, Franco-Obregón A, Wuertz K, Spaas JH. Regenerative therapies for equine degenerative joint disease: a preliminary study. PLoS One 2014;9(1):e85917.
            doi: 10.1371/journal.pone.0085917pubmed: 24465787google scholar: lookup
          83. Schnabel LV, Pezzanite LM, Antczak DF, Felippe MJ, Fortier LA. Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro. Stem Cell Res Ther 2014 Jan 24;5(1):13.
            doi: 10.1186/scrt402pubmed: 24461709google scholar: lookup
          84. Chong AK, He M. Stem cells and biological approaches to treatment of wrist problems. J Wrist Surg 2013 Nov;2(4):315-8.
            doi: 10.1055/s-0033-1357761pubmed: 24436835google scholar: lookup
          85. Lee JK, Responte DJ, Cissell DD, Hu JC, Nolta JA, Athanasiou KA. Clinical translation of stem cells: insight for cartilage therapies. Crit Rev Biotechnol 2014 Mar;34(1):89-100.
            doi: 10.3109/07388551.2013.823596pubmed: 24083452google scholar: lookup
          86. Van Pham P, Bui KH, Ngo DQ, Vu NB, Truong NH, Phan NL, Le DM, Duong TD, Nguyen TD, Le VT, Phan NK. Activated platelet-rich plasma improves adipose-derived stem cell transplantation efficiency in injured articular cartilage. Stem Cell Res Ther 2013 Aug 1;4(4):91.
            doi: 10.1186/scrt277pubmed: 23915433google scholar: lookup
          87. Barry F, Murphy M. Mesenchymal stem cells in joint disease and repair. Nat Rev Rheumatol 2013 Oct;9(10):584-94.
            doi: 10.1038/nrrheum.2013.109pubmed: 23881068google scholar: lookup
          88. Raynaud CM, Rafii A. The Necessity of a Systematic Approach for the Use of MSCs in the Clinical Setting. Stem Cells Int 2013;2013:892340.
            doi: 10.1155/2013/892340pubmed: 23864866google scholar: lookup
          89. Carrade DD, Borjesson DL. Immunomodulation by mesenchymal stem cells in veterinary species. Comp Med 2013 Jun;63(3):207-17.
            pubmed: 23759523
          90. Kopesky PW, Byun S, Vanderploeg EJ, Kisiday JD, Frisbie DD, Grodzinsky AJ. Sustained delivery of bioactive TGF-β1 from self-assembling peptide hydrogels induces chondrogenesis of encapsulated bone marrow stromal cells. J Biomed Mater Res A 2014 May;102(5):1275-85.
            doi: 10.1002/jbm.a.34789pubmed: 23650117google scholar: lookup
          91. Volk SW, Theoret C. Translating stem cell therapies: the role of companion animals in regenerative medicine. Wound Repair Regen 2013 May-Jun;21(3):382-94.
            doi: 10.1111/wrr.12044pubmed: 23627495google scholar: lookup
          92. McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis. Bone Joint Res 2012 Nov;1(11):297-309.
            doi: 10.1302/2046-3758.111.2000132pubmed: 23610661google scholar: lookup
          93. Seo MS, Park SB, Kim HS, Kang JG, Chae JS, Kang KS. Isolation and characterization of equine amniotic membrane-derived mesenchymal stem cells. J Vet Sci 2013;14(2):151-9.
            doi: 10.4142/jvs.2013.14.2.151pubmed: 23388430google scholar: lookup
          94. Goldberg VM. Stem cells in osteoarthritis. HSS J 2012 Feb;8(1):59-61.
            doi: 10.1007/s11420-011-9262-8pubmed: 23372534google scholar: lookup
          95. Ranera B, Remacha AR, Álvarez-Arguedas S, Romero A, Vázquez FJ, Zaragoza P, Martín-Burriel I, Rodellar C. Effect of hypoxia on equine mesenchymal stem cells derived from bone marrow and adipose tissue. BMC Vet Res 2012 Aug 22;8:142.
            doi: 10.1186/1746-6148-8-142pubmed: 22913590google scholar: lookup
          96. Delling U, Lindner K, Ribitsch I, Jülke H, Brehm W. Comparison of bone marrow aspiration at the sternum and the tuber coxae in middle-aged horses. Can J Vet Res 2012 Jan;76(1):52-6.
            pubmed: 22754095
          97. Wu AY, Morrow DM. Clinical use of Dieletrophoresis separation for live Adipose derived stem cells. J Transl Med 2012 May 17;10:99.
            doi: 10.1186/1479-5876-10-99pubmed: 22594610google scholar: lookup
          98. Reich CM, Raabe O, Wenisch S, Bridger PS, Kramer M, Arnhold S. Isolation, culture and chondrogenic differentiation of canine adipose tissue- and bone marrow-derived mesenchymal stem cells--a comparative study. Vet Res Commun 2012 Jun;36(2):139-48.
            doi: 10.1007/s11259-012-9523-0pubmed: 22392598google scholar: lookup
          99. Qi Y, Feng G, Yan W. Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis. Mol Biol Rep 2012 May;39(5):5683-9.
            doi: 10.1007/s11033-011-1376-zpubmed: 22183306google scholar: lookup
          100. Mensing N, Gasse H, Hambruch N, Haeger JD, Pfarrer C, Staszyk C. Isolation and characterization of multipotent mesenchymal stromal cells from the gingiva and the periodontal ligament of the horse. BMC Vet Res 2011 Aug 2;7:42.
            doi: 10.1186/1746-6148-7-42pubmed: 21810270google scholar: lookup
          101. Fortier LA, Travis AJ. Stem cells in veterinary medicine. Stem Cell Res Ther 2011 Feb 23;2(1):9.
            doi: 10.1186/scrt50pubmed: 21371354google scholar: lookup
          102. Miller RE, Grodzinsky AJ, Vanderploeg EJ, Lee C, Ferris DJ, Barrett MF, Kisiday JD, Frisbie DD. Effect of self-assembling peptide, chondrogenic factors, and bone marrow-derived stromal cells on osteochondral repair. Osteoarthritis Cartilage 2010 Dec;18(12):1608-19.
            doi: 10.1016/j.joca.2010.09.004pubmed: 20851201google scholar: lookup
          103. Kopesky PW, Vanderploeg EJ, Kisiday JD, Frisbie DD, Sandy JD, Grodzinsky AJ. Controlled delivery of transforming growth factor β1 by self-assembling peptide hydrogels induces chondrogenesis of bone marrow stromal cells and modulates Smad2/3 signaling. Tissue Eng Part A 2011 Jan;17(1-2):83-92.
            doi: 10.1089/ten.TEA.2010.0198pubmed: 20672992google scholar: lookup
          104. Gimble JM, Guilak F, Bunnell BA. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 2010 Jun 29;1(2):19.
            doi: 10.1186/scrt19pubmed: 20587076google scholar: lookup
          Subscribe to our newsletter
          Join 99,727 horse owners like you who receive our email updates on horse health and nutrition.